Magnetic resonance spectroscopy: A new guide for the therapy of adrenoleukodystrophy

Neurology

Volumn 64, Issue 3, 2005, Pages 406-407

  Moser, Hugo W ^a,b,c   Barker, Peter B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; CELL INFILTRATION; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; EDITORIAL; GENE MUTATION; GLIOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MORTALITY; NEUROIMAGING; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SPINAL CORD;

EID: 13244289781     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.64.3.406     Document Type: Editorial

References (11)

1. Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. Eighth ed. New York: McGraw Hill, 2001;3257-3301.
2. Powers JM, DeCiero DP, Cox C, et al. The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. J Neuropathol Exp Neurol 2001;60:493-501.
3. Dubey P, Fatemi A, Barker PB, et al. Spectroscopic evidence of cerebral axonopathy in pure adrenomyeloneuropathy patient. Neurology 2005 (in press).
4. Ito M, Blumberg BM, Mock DJ, et al. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 2001;60:1004-1019.
5. Peters C, Charnas LR, Tan Y, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881-888.
6. Loes D J, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15:1761-1766.
7. Moser HW, Loes DJ, Melhem ER, et al. X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 2000;31:227-239.
8. Pouwels PJ, Kruse B, Korenke GC, Mao X, Hanefeld FA, Frahm J. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254-264.
9. Eichler FS, Barker PB, Cox C, et al. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 2002;58:901-907.
10. Öz G, Tkáč I, Charnas LR, et al. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 2005;64:434-441.
11. Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X- linked adrenoleukodystrophy: initial experience. Radiology 2002;225:245-252.